Form 4: Hyster-Yale Director James Bemowski Acquires Shares Under Equity Compensation Plan

Sentiment:

SEC Form 4 Filing


Director James Bemowski acquired 528 shares of Hyster-Yale Class A Common Stock on July 1, 2024, as part of the company's Non-Employee Directors' Equity Compensation Plan.

Summary

  • On July 1, 2024, James Bemowski, a director of Hyster-Yale, acquired 528 shares of Class A Common Stock.
  • The acquisition was made under the company's Non-Employee Directors' Equity Compensation Plan.
  • The price per share was $0.
  • Following the transaction, Bemowski's direct ownership increased to 14,840 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director increasing their stake in the company through an established compensation plan, indicating confidence.

Positives

  • The acquisition of shares by a director signals confidence in the company's future.

Industry Context

This type of equity compensation is common for non-employee directors to align their interests with those of shareholders.

Comparison to Industry Standards

  • Director compensation packages often include stock awards to incentivize performance and align director interests with shareholder value.
  • Companies like Caterpillar and Deere & Company also utilize equity compensation plans for their non-employee directors.

Stakeholder Impact

  • The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates

DateDescription
07/01/2024Date of transaction: James Bemowski acquired shares of Class A Common Stock.
07/03/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.